• Create BookmarkCreate Bookmark
  • Create Note or TagCreate Note or Tag
  • PrintPrint
Share this Page URL
Help

Chapter 6. Growing Mushrooms: The Art of... > Red Flag 21: When Drug Companies Spi...

Red Flag 21: When Drug Companies Spin and Obfuscate the Results of Drug Trials

One of the riskier areas for mainstream investors is the biotechnology industry, where U.S. regulators have done little to rein in companies making confusing or exaggerated claims about drug trial results. Clinical trials make or break a drug’s chances of being approved by the U.S. Federal Drug Administration (FDA), so the results of a major trial can often send a share price for a ride and can make the difference between survival and closure for some smaller companies.


PREVIEW

                                                                          

Not a subscriber?

Start A Free Trial


  
  • Creative Edge
  • Create BookmarkCreate Bookmark
  • Create Note or TagCreate Note or Tag
  • PrintPrint